Latest News and Press Releases
Want to stay updated on the latest news?
Featured Releases
-
Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market
Read More -
GEORGE TOWN, Cayman Islands, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Toobit, the award-winning global cryptocurrency exchange, today announces the release of its 2025 Recap. This personalized...
Read More
-
Chicago, Jan. 15, 2026 (GLOBE NEWSWIRE) -- According to recent data from Astute Analytica, the global automotive wiring harness market was valued at US$ 70.48 billion in 2024 and is projected to hit...
-
Gesture Recognition Market Size, Share & Segmentation By Component, By Technology, By Application, By End User, Region, And Global Forecast 2026-2033
-
Reports Q4-2025 Production, Record Annual Production, Production Guidance Achieved & Operational Highlights Serabi Gold plc (“Serabi” or the “Company”) (AIM:SRB, TSX:SBI, OTCQX:SRBIF), the...
-
Sampo plc, stock exchange release, 15 January 2026 at 8:30 am EET Sampo plc’s share buybacks 14 January 2026 On 14 January 2026, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has...
-
We are investigating whether Trip.com Group has violated the federal securities laws.
-
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR15 JANUARY 2026 RICHEMONT MAINTAINED STRONG MOMENTUM WITH SALES UP 11% AT CONSTANT RATES FOR ITS THIRD QUARTER ENDED 31 DECEMBER 2025 Highlights for the...
-
Ad hoc announcement pursuant to Art. 53 LRBaar (Switzerland), 15 January 2026Based on preliminary unaudited figures, Ascom reports for fiscal year 2025 net revenue of CHF 292.1 million, which is an...
-
Stablepharma and AFT Pharmaceuticals (NZX: AFT; ASX: AFP) partner to address multi-billion dollar anti-infective and oncology therapeutics market
-
TGS is pleased to announce APEX 1, a first-of-its-kind, next-generation multi-client long-offset OBN acquisition campaign in the Gulf of America.
-
Commercial launch in Switzerland anticipated in H2 2026 Pratteln, Switzerland, January 15, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces that the Swiss Agency for Therapeutic Products...